Contrast‐Enhanced Ultrasound (CEUS) in the Evaluation of Hemoperitoneum in Patients With Cirrhosis. (17th May 2022)

• Record Type: Journal Article
• Authors: Abushamat, Farid; Dietrich, Christoph F.; Clevert, Dirk‐Andre; Piscaglia, Fabio; Fetzer, David T.; Meloni, Maria Franca; Shiehmorteza, Masoud; Kono, Yuko
• Is Part Of: Journal of ultrasound in medicine. Volume 42:Number 1(2023)
• Page Start: 247
• Page End: 253
• Publication Date: 2022-05-17
• Subjects: CEUS -- cirrhosis -- bleeding -- hemoperitoneum; Ultrasonics in medicine -- Periodicals; Ultrasonics; Ultrasonography; Ultrasonics in medicine; Electronic journals; Periodicals; Periodicals; 616.07543
• DOI: 10.1002/jum.16002
• Languages: English
• ISSNs: 0278-4297

Abstract

Abstract : Hemoperitoneum in cirrhosis is a life‐threatening condition that requires emergent evaluation. Contrast‐enhanced ultrasound (CEUS) permits multiple dynamic characterizations of abdominal structures through all vascular phases, and contrast extravasation or the presence of microbubbles in the ascites could be a sensitive tool. We reviewed 13 patients with cirrhosis that underwent CEUS due to high suspicion for intra‐abdominal bleeding. In 10 cases, CEUS demonstrated extravasation of contrast, including 2 instances where CEUS detected active bleeding despite negative computed tomography. These data support further study of CEUS in direct comparison to other imaging modalities in this clinical context.